Paper8467488
Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
Evans CA and 3 others. Cancer Res, 1993. Cited by 170 papers, by iCite.
Cite this record
ConductScience Library. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. Papers, record 8467488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8467488
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Abelson murine leukemia virus | Major topic |
| Apoptosis | Major topic |
| Interleukin-3 | Major topic |
| Mast Cells | Major topic |
| Oncogene Proteins v-abl | Major topic |
| Protein-Tyrosine Kinases | Major topic |
| Animals | |
| Cell Line | |
| Enzyme Activation | |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | |
| Mice |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 170 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31881245 | Lyn regulates creatine uptake in an imatinib-resistant CML cell line. | Biochim Biophys Acta Gen Subj | 2020 | https://conductscience.org/library/papers/31881245 | PubMed |
| 25983693 | The study of homology between tumor progression genes and members of retroviridae as a tool to predict target-directed therapy failure. | Front Pharmacol | 2015 | https://conductscience.org/library/papers/25983693 | PubMed |
| 22514484 | Apoptosis: Molecular mechanisms, regulation and role in pathogenesis. | Can J Infect Dis | 1997 | https://conductscience.org/library/papers/22514484 | PubMed |
| 20068223 | Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells. | Blood | 2010 | https://conductscience.org/library/papers/20068223 | PubMed |
| 15014528 | Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL. | Leukemia | 2004 | https://conductscience.org/library/papers/15014528 | PubMed |
| 12835715 | Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies. | Leukemia | 2003 | https://conductscience.org/library/papers/12835715 | PubMed |
| 12476305 | Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571. | Oncogene | 2002 | https://conductscience.org/library/papers/12476305 | PubMed |
| 12114808 | Apoptosis in Endocrine Glands. | Endocr Pathol | 1995 | https://conductscience.org/library/papers/12114808 | PubMed |
| 12040447 | Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571. | Leukemia | 2002 | https://conductscience.org/library/papers/12040447 | PubMed |
| 11960331 | Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. | Leukemia | 2002 | https://conductscience.org/library/papers/11960331 | PubMed |
| 11840288 | Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest. | Leukemia | 2002 | https://conductscience.org/library/papers/11840288 | PubMed |
| 10939520 | Hydrogen peroxide-induced apoptosis in human hepatoma cells is mediated by CD95(APO-1/Fas) receptor/ligand system and may involve activation of wild-type p53. | Mol Biol Rep | 2000 | https://conductscience.org/library/papers/10939520 | PubMed |
| 10648603 | The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/10648603 | PubMed |
| 10536003 | Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10536003 | PubMed |
| 9154822 | Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells. | Mol Cell Biol | 1997 | https://conductscience.org/library/papers/9154822 | PubMed |
| 9106363 | Kinase cascades regulating entry into apoptosis. | Microbiol Mol Biol Rev | 1997 | https://conductscience.org/library/papers/9106363 | PubMed |
| 8917729 | Role of protein kinase activity in apoptosis. | Experientia | 1996 | https://conductscience.org/library/papers/8917729 | PubMed |
| 8917556 | Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8917556 | PubMed |
| 8260364 | Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8260364 | PubMed |
| 8178928 | Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. | Am J Pathol | 1994 | https://conductscience.org/library/papers/8178928 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8467488
GET https://conductscience.org/api/papers/v1/8467488/cited_by?page=2